Literature DB >> 34587763

Practice Patterns and Patient Outcomes After Widespread Adoption of Remote Heart Failure Care.

Neal Yuan1, Patrick G Botting1, Yaron Elad1,2, Shaun J Miller3,2, Susan Cheng1, Joseph E Ebinger1, Michelle M Kittleson1.   

Abstract

BACKGROUND: An unprecedented shift to remote heart failure outpatient care occurred during the coronavirus disease 2019 (COVID-19) pandemic. Given challenges inherent to remote care, we studied whether remote visits (video or telephone) were associated with different patient usage, clinician practice patterns, and outcomes.
METHODS: We included all ambulatory cardiology visits for heart failure at a multisite health system from April 1, 2019, to December 31, 2019 (pre-COVID) or April 1, 2020, to December 31, 2020 (COVID era), resulting in 10 591 pre-COVID in-person, 7775 COVID-era in-person, 1009 COVID-era video, and 2322 COVID-era telephone visits. We used multivariable logistic and Cox proportional hazards regressions with propensity weighting and patient clustering to study ordering practices and outcomes.
RESULTS: Compared with in-person visits, video visits were used more often by younger (mean 64.7 years [SD 14.5] versus 74.2 [14.1]), male (68.3% versus 61.4%), and privately insured (45.9% versus 28.9%) individuals (P<0.05 for all). Remote visits were more frequently used by non-White patients (35.8% video, 37.0% telephone versus 33.2% in-person). During remote visits, clinicians were less likely to order diagnostic testing (odds ratio, 0.20 [0.18-0.22] video versus in-person, 0.18 [0.17-0.19] telephone versus in-person) or prescribe β-blockers (0.82 [0.68-0.99], 0.35 [0.26-0.47]), mineralocorticoid receptor antagonists (0.69 [0.50-0.96], 0.48 [0.35-0.66]), or loop diuretics (0.67 [0.53-0.85], 0.45 [0.37-0.55]). During telephone visits, clinicians were less likely to prescribe ACE (angiotensin-converting enzyme) inhibitor/ARB (angiotensin receptor blockers)/ARNIs (angiotensin receptor-neprilysin inhibitors; 0.54 [0.40-0.72]). Telephone visits but not video visits were associated with higher rates of 90-day mortality (1.82 [1.14-2.90]) and nonsignificant trends towards higher rates of 90-day heart failure emergency department visits (1.34 [0.97-1.86]) and hospitalizations (1.36 [0.98-1.89]).
CONCLUSIONS: Remote visits for heart failure care were associated with reduced diagnostic testing and guideline-directed medical therapy prescription. Telephone but not video visits were associated with increased 90-day mortality.

Entities:  

Keywords:  ambulatory care; coronavirus; guideline adherence; heart failure; telemedicine; videoconferencing

Mesh:

Year:  2021        PMID: 34587763      PMCID: PMC8530957          DOI: 10.1161/CIRCHEARTFAILURE.121.008573

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN: 1941-3289            Impact factor:   10.447


  27 in total

1.  Clinical features, laboratory characteristics, and outcomes of patients hospitalized with coronavirus disease 2019 (COVID-19): Early report from the United States.

Authors:  Saurabh Aggarwal; Nelson Garcia-Telles; Gaurav Aggarwal; Carl Lavie; Giuseppe Lippi; Brandon Michael Henry
Journal:  Diagnosis (Berl)       Date:  2020-05-26

2.  Doubly robust estimation of causal effects.

Authors:  Michele Jonsson Funk; Daniel Westreich; Chris Wiesen; Til Stürmer; M Alan Brookhart; Marie Davidian
Journal:  Am J Epidemiol       Date:  2011-03-08       Impact factor: 4.897

Review 3.  Remote monitoring in heart failure: current and emerging technologies in the context of the pandemic.

Authors:  Donya Mohebali; Michelle M Kittleson
Journal:  Heart       Date:  2021-01-11       Impact factor: 5.994

4.  Virtual Versus In-Person Visits and Appointment No-Show Rates in Heart Failure Care Transitions.

Authors:  Eiran Z Gorodeski; Laurie Ann Moennich; Haris Riaz; Lara Jehi; James B Young; W H Wilson Tang
Journal:  Circ Heart Fail       Date:  2020-07-30       Impact factor: 8.790

5.  Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial.

Authors:  William T Abraham; Philip B Adamson; Robert C Bourge; Mark F Aaron; Maria Rosa Costanzo; Lynne W Stevenson; Warren Strickland; Suresh Neelagaru; Nirav Raval; Steven Krueger; Stanislav Weiner; David Shavelle; Bradley Jeffries; Jay S Yadav
Journal:  Lancet       Date:  2011-02-19       Impact factor: 79.321

6.  Incidence of New-Onset and Worsening Heart Failure Before and After the COVID-19 Epidemic Lockdown in Denmark: A Nationwide Cohort Study.

Authors:  Charlotte Andersson; Thomas Gerds; Emil Fosbøl; Matthew Phelps; Julie Andersen; Morten Lamberts; Anders Holt; Jawad H Butt; Christian Madelaire; Gunnar Gislason; Christian Torp-Pedersen; Lars Køber; Morten Schou
Journal:  Circ Heart Fail       Date:  2020-06-02       Impact factor: 8.790

7.  Telemedicine Outpatient Cardiovascular Care During the COVID-19 Pandemic: Bridging or Opening the Digital Divide?

Authors:  Lauren A Eberly; Sameed Ahmed M Khatana; Ashwin S Nathan; Christopher Snider; Howard M Julien; Mary Elizabeth Deleener; Srinath Adusumalli
Journal:  Circulation       Date:  2020-06-08       Impact factor: 39.918

8.  The Next Wave of Health Care Strain Related to COVID-19: Heart Failure Patients Coming Back in Force-We Must Not Fail Them.

Authors:  Yasbanoo Moayedi; Ana C Alba; Douglas S Lee; Harindra C Wijeysundera; Heather J Ross
Journal:  Can J Cardiol       Date:  2020-06-03       Impact factor: 5.223

9.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.

Authors:  Fei Zhou; Ting Yu; Ronghui Du; Guohui Fan; Ying Liu; Zhibo Liu; Jie Xiang; Yeming Wang; Bin Song; Xiaoying Gu; Lulu Guan; Yuan Wei; Hui Li; Xudong Wu; Jiuyang Xu; Shengjin Tu; Yi Zhang; Hua Chen; Bin Cao
Journal:  Lancet       Date:  2020-03-11       Impact factor: 79.321

10.  Temporal trends in decompensated heart failure and outcomes during COVID-19: a multisite report from heart failure referral centres in London.

Authors:  Antonio Cannatà; Daniel I Bromage; Irfan A Rind; Caterina Gregorio; Clare Bannister; Mohammed Albarjas; Susan Piper; Ajay M Shah; Theresa A McDonagh
Journal:  Eur J Heart Fail       Date:  2020-09-28       Impact factor: 17.349

View more
  2 in total

1.  Reply: Telehealth: The Future of Consultations?

Authors:  Yasser Sammour; John A Spertus; Islam Shatla; Michael L Main; Brett W Sperry
Journal:  JACC Heart Fail       Date:  2022-04       Impact factor: 12.035

Review 2.  Preventive Cardiology in the Digital and COVID-19 Era: A Brave New World within the Veterans Health Administration.

Authors:  Sohil Khanna; Arash Harzand
Journal:  Healthcare (Basel)       Date:  2021-11-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.